Results 181 to 190 of about 1,829,207 (256)
Abstract Background Internalising and externalising behaviours—significant markers for lifetime psychiatric vulnerability—are elevated in children with neurodevelopmental diagnoses, including autism. Although neurodevelopmental features of autism are dimensions that span the population, limited research has examined their differential patterns of ...
Sarah J. Carrington +5 more
wiley +1 more source
Mitochondrial Dysfunction Across the Addiction Cycle: A Stage-Resolved Narrative Review. [PDF]
Jamali Z, Salimi A, Isazadehfar K.
europepmc +1 more source
Abstract Background Neurodivergent youth and youth with pre‐existing psychiatric disorders may have faced additional challenges in navigating the demands and restrictions of the COVID‐19 pandemic. However, less is known about how mental health outcomes and psychiatric healthcare utilization differed across diagnostic groups and other youth‐related ...
Ulyana Sirotina +10 more
wiley +1 more source
Gabapentin for the Management of Suspected Cannabis Withdrawal in a Pregnant Patient With a History of Cannabinoid Hyperemesis Syndrome: A Case Report. [PDF]
Turcotte AM +5 more
europepmc +1 more source
Abstract Background Youth (aged 15–24 years) diagnosed with neurodevelopmental disorders (NDD) experience higher rates of co‐occurring mental health challenges and disparities in receiving timely care. A significant barrier to support is a lack of guidance for healthcare professionals (HCPs) on delivering conversations about co‐occurring mental health ...
Patrick Jachyra +12 more
wiley +1 more source
Long-Acting Injectable Buprenorphine in Pregnancy. [PDF]
Nacev EC +5 more
europepmc +1 more source
Abstract Patients with substance use disorder (SUD) represent a high‐complexity, high‐cost population on hospital medicine services, yet their admissions are systematically under‐reimbursed due to narrow clinical documentation. Increasingly, hospital‐based addiction consultation service (ACS) clinicians provide dedicated addiction care to medically ...
Philip A. Durney +2 more
wiley +1 more source
Novel pharmacotherapies for opioid use disorder and opioid withdrawal. [PDF]
Shen MR +6 more
europepmc +1 more source

